FAAIS Position Statements

Read our statements below for the Florida Allergy, Asthma & Immunology Society’s official stance on issues relevant to our doctors and patients.

• Assuring Patient Access to Subcutaneous Allergen Immunotherapy (May 2017)
• Epinephrine Use for the Treatment of Severe Allergic Food Reactions (Dec. 2016)
• Escalating Cost of Epinephrine Auto-Injectors and Impact on Patient Access to Epinephrine (Aug. 2016)
• Letter to ER Departments (Aug. 2015)
• Anaphylaxis in the School Setting: Guidelines for Rapid Recognition and Treatment (Feb.2014)
• Restricted access to Advair™ in children aged 4-11 years of age (Jan. 2014)